IDT played a pivotal role in manufacturing the personalized gene editing therapy given to baby KJ Muldoon to treat his rare ...
A year after receiving the world’s first personalized base-editing therapy for a lethal CPS1 gene mutation, Baby KJ is healthy and has avoided a liver transplant. The unprecedented treatment, ...
Artificial intelligence is rapidly transforming CRISPR genome editing, making it faster, safer, and more precise. From designing guide RNAs to engineering novel enzymes, AI is streamlining workflows ...
Diabetes mellitus affects more than 500 million people worldwide, and both Type 1 (T1D) and Type 2 (T2D) forms converge on a common endpoint: the loss or ...